Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $6.9500 (-2.18%) ($6.9500 - $7.1700) on Tue. Aug. 15, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.14% (three month average) | RSI | 38 | Latest Price | $6.9500(-2.18%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.1% a day on average for past five trading days. | Weekly Trend | BCRX declines -3.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(36%) VIXM(24%) USO(19%) XLE(19%) OIH(18%) | Factors Impacting BCRX price | BCRX will decline at least -1.57% in a week (0% probabilities). XLRE(-42%) XLP(-39%) XLV(-29%) SPLV(-27%) EWG(-27%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.57% (StdDev 3.14%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-1.27(-118.27%) | Resistance Level | $7.25 | 5 Day Moving Average | $7.01(-0.86%) | 10 Day Moving Average | $7.05(-1.42%) | 20 Day Moving Average | $7.25(-4.14%) | To recent high | -21.5% | To recent low | 3.7% | Market Cap | $1.226b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |